← Back to all trials
Recruiting
NCT07746427
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Conditions: Atopic Dermatitis, Eczema
Sex: All
Ages: 13 Years – 17 Years
Healthy volunteers: No
Phase: NA
Enrollment: 40
Sponsor: Weill Medical College of Cornell University
Location: Weill Cornell Medicine New York New York
Summary
Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.
Eligibility Criteria
Inclusion Criteria
* Adolescents age 13-17 years.
* Atopic dermatitis refractory to standard topical treatment including topical steroids or topical calcineurin inhibitors.
* Moderate to severe atopic dermatitis via PO-SCORAD score on enrollment.
Exclusion Criteria
* Started on a biologic agent (i.e. dupxient) within the past 3 months.
* Mild atopic dermatitis via PO-SCORAD score on enrollment.
Source: ClinicalTrials.gov (NCT07746427). StuddyBuddy aggregates publicly available trial information.